Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

CYTKCytokinetics, Incorporated

$8B

Q2 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M

Gross Profit

-$4M-67.6% margin

Operating Income

-$11M-189.8% margin

Net Income

-$12M-200.1% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

-31.1%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$106M

Total Liabilities

$57M

Stockholders' Equity

$49M

Cash & Equivalents

$28M

← FY 2016 All Quarters Q3 2016 →

CYTK Q2 2016 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena